Contact the Board's Consumer Information Unit for assistance.
1 (800) 633-2322Send a Message
Naloxone Prescription Requirements
AB 2760 (Wood, Chapter 324) was signed into law in 2018 and becomes effective on January 1, 2019. This bill requires prescribers to offer a prescription for naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression to a patient when certain conditions, which are specified in the bill, are present. This bill also requires a prescriber, consistent with the existing standard of care, to provide education to a patient and their designee, or if the patient is a minor, to the patient’s parent or guardian, on overdose prevention and the use of naloxone or other similar drug approved by the FDA.